Calcium, zinc, copper and iron. Minerals work in ratio, and supplementing one without measuring its partner is the mechanism behind most of the harm here.
The Women's Health Initiative found that women taking calcium supplements had significantly increased risk of myocardial infarction, not decreased. The Bolland et al. meta-analyses (2010, 2011) confirmed this: calcium supplementation without adequate cofactors increases cardiovascular events by 20–30%. The mechanism is straightforward. Calcium taken as an isolated mineral floods the bloodstream. Without the enzymatic cofactor matrix (magnesium, silicon, boron, vitamins A, D, and K2 in whole-food form) the body cannot direct that calcium into bone. It deposits instead in arterial walls, soft tissue, and joints. Supplemental calcium does not treat osteoporosis. It treats the fear of osteoporosis while building atherosclerosis.
Bone is not calcium. Bone is a living collagen matrix in which calcium, phosphorus, magnesium, and trace minerals are embedded. Weight-bearing physical activity, sunlight-derived vitamin D, and mineral-dense whole food (dairy from pastured animals, sardines with bones, mineral-rich leafy greens, bone broth) provide the matrix and the minerals together. Isolated calcium, especially calcium carbonate (which is chalk), bypasses all of it.
Zinc and copper compete for the same transporters in the gut. Supplementing zinc at doses above 25–40 mg daily, the range found in many immune support products, progressively blocks copper absorption. Copper deficiency, particularly when chronic, produces a clinical picture that is rarely attributed to the supplement causing it: anemia that does not respond to iron, neurological symptoms including peripheral neuropathy, myelopathy, and cognitive decline, immune suppression (the opposite of the intended effect), and bone marrow failure. Cases of copper-deficiency myelopathy from long-term zinc supplementation have been reported in the medical literature. The supplemented person typically does not connect their neurological deterioration to the zinc they have been taking for years to "support immunity."
Acute high-dose zinc (above 150 mg) causes nausea, vomiting, and GI hemorrhage. Chronic moderate overdose depletes copper and suppresses HDL cholesterol. The ionic zinc in lozenges and high-dose supplements is not the same as zinc from whole food. Oysters, red meat, pumpkin seeds, and liver provide zinc in its natural cofactor matrix, at bioavailable levels the body can regulate. The supplement does not regulate. The gut absorbs what it receives, and the transporter competition with copper is the consequence.
Copper deficiency is real. It is also increasingly common: driven largely by widespread zinc oversupplementation (covered above), high-fructose corn syrup consumption (which directly impairs copper absorption), and the phytic acid load from grain-heavy diets. The symptoms of copper deficiency overlap with many common complaints: fatigue, poor immunity, anemia that doesn't respond to iron, bone fragility, and neurological symptoms. The supplement industry's response is predictable: sell isolated copper supplements. The problem is that isolated copper, like every other isolated mineral, does not arrive in the body with the regulatory context that makes it safe and functional. Copper metabolism depends on ceruloplasmin (a copper-transport protein), ferroxidase activity, and a precise ratio with zinc, iron, and molybdenum. Supplementing copper without this context does not restore copper metabolism. It floods a compromised system.
The high-copper/low-zinc state has been studied extensively in the context of psychiatric illness, particularly by Dr. William Walsh at the Walsh Research Institute. Elevated serum copper with depressed zinc is documented in a significant subset of patients with schizophrenia, bipolar disorder, depression, and violent behavior. Copper is a cofactor for dopamine-beta-hydroxylase, the enzyme that converts dopamine to norepinephrine. Excess copper drives excess norepinephrine production and depletes dopamine, producing a neurochemical profile associated with anxiety, paranoia, hyperactivity, and in severe cases, psychosis. This is not copper being generally bad. It is the isolated imbalance being specifically damaging. Supplementing copper in a person who already has elevated copper and undetected zinc depletion can precipitate or worsen psychiatric symptoms. The supplement has no way of knowing which situation it is entering.
Copper is excreted primarily through bile. Anything that impairs bile flow (liver disease, gallbladder dysfunction, constipation, or the cholestatic effect of oral contraceptives and synthetic estrogens) causes copper to accumulate. Women on oral contraceptives have measurably elevated serum copper as a documented pharmacological effect of estrogen. Women who are already copper-dominant and begin supplementing copper, often on the advice of social media content about "adrenal support" or "thyroid function", may be dramatically worsening an existing copper overload. Wilson's disease is the extreme genetic end of this problem (impaired copper excretion), but subclinical copper accumulation in people with compromised bile metabolism is far more common and far less recognized. Symptoms of copper toxicity include: nausea, liver pain, fatigue, brain fog, emotional lability, insomnia, and the full psychiatric picture described above. These are often attributed to everything except the copper supplement the person started six months ago.
The serum zinc-to-copper ratio is one of the most clinically informative values in functional medicine, more meaningful than either value alone. An optimal ratio is approximately 1:1 (with zinc slightly higher). A high copper/low zinc ratio drives the psychiatric and neurological picture described above. A high zinc/low copper ratio (from zinc oversupplementation) produces the copper deficiency neurological picture: myelopathy, peripheral neuropathy, immune collapse. Neither can be corrected by supplementing the low mineral without simultaneously addressing the high one and the underlying reason for the imbalance. Supplementing copper because a blood test showed "low copper" without measuring zinc, ceruloplasmin, and assessing the clinical context is the equivalent of adding oil to an engine without checking if there is a leak. The oil is not the problem. The leak is.
Unbound iron catalyzes the Fenton reaction: converting hydrogen peroxide to hydroxyl radicals, the most reactive and destructive free radicals in biology. Ferritin above 200 ng/mL is independently associated with increased risk of liver cancer, colorectal cancer, and cardiovascular disease. Iron supplementation without confirmed deficiency adds to this pool. The Iowa Women's Health Study (Mursu et al., 2011) found iron supplementation was the single supplement most strongly associated with increased mortality in older women. Yet iron supplements are sold over the counter, recommended liberally for fatigue, and given without follow-up ferritin testing. The consequence of iron overload is organ damage (liver, heart, pancreas) and increased oxidative burden throughout the body.
Iron cannot be properly loaded into transferrin and transported without ceruloplasmin, a copper-containing protein. Low ceruloplasmin (driven by copper deficiency, common in those supplementing zinc. See above) means iron accumulates in tissue rather than being transported and used. A person with low ceruloplasmin who supplements iron is increasing stored iron without increasing functional iron. The clinical result is continued fatigue alongside rising ferritin, which is typically met with more iron, not an investigation of ceruloplasmin or copper status. Whole-food sources of iron (red meat, liver, shellfish) come packaged with the copper needed for their own metabolism.